Bristol Myers Squibb Reports Phase 3 EXCALIBER-RRMM Results Showing Higher MRD-Negative Responses With ZENBEXUS in Relapsed or Refractory Multiple Myeloma Bristol Myers Squibb (NYSE: BMY) has announced the first presentation…
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Partnership With Pepperdine E2B Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with Pepperdine E2B™ (Education to…
Susan G. Komen to Host Austin MORE THAN PINK Walk to Support Breast Cancer Research and Patient Care Susan G. Komen®, a leading breast cancer organization, is preparing to host…
Quanterix Advances Spatial Biology Content Innovation Engine With New Cancer Research Tools Quanterix Corporation (NASDAQ: QTRX) has reported further progress on its Content Innovation Engine, a strategic initiative introduced at…
Alume Biosciences Receives FDA Breakthrough Therapy Designation for Bevonescein in Intraoperative Nerve Visualization Alume Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation…
Aptar Pharma and Macquarie University Launch Research Program to Advance Inhaled Biologic Delivery Aptar Pharma, a global provider of drug delivery, dosing and protection technologies and services, has announced a…
FDA Approves WELIREG Plus LENVIMA for Previously Treated Advanced Clear Cell Renal Cell Carcinoma Merck, known as MSD outside the United States and Canada, and Eisai announced that the U.S.…
New Paper Provides Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansions Slipstream, a technology consulting partner focused exclusively on the life sciences industry, has announced the…
Cresco Labs Files Proxy Materials for October Shareholder Meeting as It Advances U.S. Exchange Listing Plans Cresco Labs Inc. has filed its Management Information Circular and related proxy materials ahead…
Altasciences Supports 4B Healthcare’s RhineX Nasal Rinse Program Toward Phase I Clinical Testing Altasciences has announced that its recent drug product development and manufacturing work for 4B Healthcare Inc. has…
New Data Shows Breast Cancer Index Testing Influences Extended Endocrine Therapy Decisions Hologic, Inc. and its subsidiary Biotheranostics, Inc. have announced new findings from the Breast Cancer Index (BCI) Registry…
Countable Labs Enters Clinical Market With Ancora Oncology Assays Powered by Single-Molecule PCR Technology Countable Labs, a developer of advanced molecular testing technologies, has announced its entry into the clinical…